Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CD40:CD154 binding interrupter compounds and use thereof to treat immunological complications

CD40:CD154 binding interrupter compounds and use thereof to treat immunological complications

US Patent 7173046 · Granted Feb 6, 2007

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of plasma kallikrein and uses thereof2025
Smoking substitute devices and associated methods, systems and apparatuses2025
Methods of using substituted pyrazole and pyrazole compounds and for treatment o2024
Skeleton representation of layouts for the development of lithographic masks2024
Recombinant intravenous immunoglobulin (RIVIG) compositions and methods for thei2023
Electronic system, portable electronic device and counting information updating 2023
Wound healing composition2023
Wearable electronic device and assembling method thereof2023
Substituted pyrazole and pyrrole compounds and methods for using them for inhibi2023
Biaryl inhibitors of Bruton's tyrosine kinase2023
Inhibitors of plasma kallikrein and uses thereof2022
Substituted pyrazole compounds and methods of using them for treatment of hyperp2022